Skip to main content
ANAGENICS LIMITED logo

ANAGENICS LIMITED — Investor Relations & Filings

Ticker · AN1 ISIN · AU0000198095 ASX Manufacturing
Open in API
Filings indexed 1,067 across all filing types
Latest filing 2018-03-25 Director's Dealing
Country AU Australia
Listing ASX AN1

About ANAGENICS LIMITED

https://anagenics.com

Anagenics Limited is a health and wellness company focused on the development and commercialization of science-based anti-aging and longevity solutions. The company specializes in the research and distribution of clinically validated products targeting hair loss and skin health. Its core portfolio includes the évolis brand, which utilizes proprietary FGF5 inhibitor technology to promote hair growth and improve hair health. Through its subsidiaries, such as Advangen and BLC Cosmetics, the company manages a diverse range of premium skincare and wellness brands. Anagenics operates across international markets, providing consumer-facing products and professional-grade treatments backed by scientific research. The company's strategic focus remains on expanding its presence in the global beauty-tech and wellness sectors by leveraging its intellectual property and distribution networks.

Recent filings

Filing Released Lang Actions
Initial Director's Interest Notice 2 pages 11.2KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3X Initial Director’s Interest Notice' and references ASX listing rule 3.19A.1 and section 205G of the Corporations Act. It details the director's relevant interests in securities, including the number and class of securities held by the director, and notes about contracts related to the director's interests. This is a report of personal share transactions or holdings by a company director. The document length is short (2116 characters) and contains specific information about director shareholdings, which matches the definition of Director's Dealing filings. Therefore, the document is classified as a Director's Dealing report (DIRS).
2018-03-25 English
Change of Director's Interest Notice-Halasz 3 pages 223.2KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in a director's relevant interests in securities, including the number of shares held before and after the change, the nature of the change, and whether the trade occurred during a closed period. This is a report of personal share transactions by a company director. The document length is 3553 characters, which is consistent with a detailed director's dealing notice. Therefore, this document fits the definition of 'Director's Dealing' (DIRS).
2018-03-13 English
Appendix 4D and Half Year Accounts 27 pages 217.7KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'ASX APPENDIX 4D RESULTS FOR ANNOUNCEMENT TO THE MARKET FOR THE HALF YEAR ENDED 31 DECEMBER 2017' and contains detailed financial results, operational reviews, and an interim financial report for the half-year period ending 31 December 2017. It includes financial statements such as the Statement of Profit or Loss, Statement of Financial Position, and Notes to the Financial Statements, as well as an Independent Auditor's Review Report. The presence of comprehensive financial data and analysis for a period shorter than a full fiscal year, along with the half-year date references, clearly identifies this as an Interim / Quarterly Report. The document is approximately 15,000 characters long, indicating it is the full report rather than a brief announcement or certification. Therefore, the correct classification is 'IR' (Interim / Quarterly Report). H1 2018
2018-02-21 English
Change of Director's Interest Notice-Halasz 3 pages 223.1KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in a director's relevant interests in securities, including the number of shares held before and after the change, the nature of the change, and dates. This is a formal notification of a director's personal share transactions. The document length is 3560 characters, which is consistent with a detailed director's dealing notice. There is no financial performance data, earnings information, or management discussion. Therefore, this document fits the definition of Director's Dealing (DIRS).
2018-01-30 English
Appendix 4C - quarterly 6 pages 238.8KB
Interim / Quarterly Report Classification · 100% confidence The document is titled as an ASX Announcement and specifically refers to "Notes to the Appendix 4C" for the second quarter of the 2018 financial year. Appendix 4C is a standard quarterly cash flow report required by the ASX Listing Rules (Rule 4.7B). The document contains detailed quarterly cash flow statements, including operating, investing, and financing activities, as well as reconciliation of cash and cash equivalents. It also includes a compliance statement signed by the CEO. The document length is over 11,000 characters, indicating it is a substantive report rather than a brief announcement. The content and format clearly identify it as a quarterly financial report, which corresponds to an Interim / Quarterly Report (IR) filing type. Q2 2018
2018-01-24 English
RECORD 2M SALES FOR CELLMID FGF5 INHIBITORS 1 page
Capital/Financing Update Classification · 85% confidence The document is an ASX announcement reporting record sales figures for Cellmid Limited's FGF5 inhibitor products for the second quarter of FY2018. It provides specific sales data and business updates but does not contain comprehensive financial statements or detailed financial analysis typical of quarterly or annual reports. The document is relatively short (2284 characters) and focuses on sales performance highlights rather than full financial results. Therefore, it fits best as a Capital/Financing Update (CAP) since it updates on company sales performance, which is related to financing and capital activities, rather than a full Interim Report (IR) or Earnings Release (ER) which would typically include broader financial results and analysis. It is not an Earnings Release because it lacks key highlights of quarterly financial results beyond sales figures, and it is not a Regulatory Filing or Report Publication Announcement as it is a substantive announcement of sales performance.
2018-01-09 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.